Revivo Therapeutics

Revivo Therapeutics is a clinical stage pharmaceutical company, developing treatments for cognitive impairment.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Williamsburg, VA, USA
  • Currency USD
  • Founded June 2018
  • Employees 6
  • Incorporation Type C-corp
  • Website revivotherapeutics.com

Company Summary

Revivo is a clinical stage pharma company developing a memory enhancer for the early stages of Mild Cognitive Impairment related to Alzheimer’s disease and Traumatic Brain Injury.
Revivo is anticipating the start of clinical trials in early 2023. Revivo’s technology is based on prior Nobel Prize-winning research on learning and memory. The company is led by a team of drug developers with >150 years of combined experience in pharma.

Team

  • Doug Cowart
    CEO Revivo Therapeutics

    Dr. Cowart has over 35 years of experience in pharmaceutical business and pharmaceutical research and development. He has played lead business as well as research and development roles in small and large pharmaceutical companies. He has been involved acquisitions and mergers and asset acquisitions by major pharmaceutical companies.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free